Maria Teresa Landi, MD, PhD

Articles

Dr. Landi Discusses the Importance of Screening in Melanoma

January 9th 2018

Maria Teresa Landi, MD, PhD, senior investigator, Integrative Tumor Epidemiology Branch, National Cancer Institute, discusses the importance of screening in melanoma.

Dr. Landi on the Association Between Genetic Variance and Melanoma Risk

December 14th 2017

Maria Teresa Landi, MD, PhD, senior investigator, Integrative Tumor Epidemiology Branch, National Cancer Institute, discusses the association between genetic variance and melanoma risk.